← Back to directory

Péter Hauser

Researcher Next ID · RN-019443

Researcher · Medicine

University of California, Riverside

Riverside, Hungary

Not currently recruitingFunding unknown
Works count
215
Citation count
16,247
H-index
50
i10-index
91

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Glioma Diagnosis and Treatment
Sarcoma Diagnosis and Treatment
Chromatin Remodeling and Cancer
Cancer, Hypoxia, and Metabolism
Neuroblastoma Research and Treatments

Publications

  • Failure of human rhombic lip differentiation underlies medulloblastoma formation

    Nature · 2022 · 10.1038/s41586-022-05215-w

  • Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis

    Cell · 2020 · 10.1016/j.cell.2020.11.012

  • High-Dose Chemotherapy Compared With Standard Chemotherapy and Lung Radiation in Ewing Sarcoma With Pulmonary Metastases: Results of the European Ewing Tumour Working Initiative of National Groups, 99 Trial and EWING 2008

    Journal of Clinical Oncology · 2019 · 10.1200/jco.19.00915

  • The molecular landscape of ETMR at diagnosis and relapse

    Nature · 2019 · https://doi.org/10.1038/s41586-019-1815-x

  • Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohort

    The Lancet Oncology · 2018 · 10.1016/s1470-2045(18)30242-0

  • Intertumoral Heterogeneity within Medulloblastoma Subgroups

    Cancer Cell · 2017 · https://doi.org/10.1016/j.ccell.2017.05.005

  • Therapeutic and Prognostic Implications of BRAF V600E in Pediatric Low-Grade Gliomas

    Journal of Clinical Oncology · 2017 · 10.1200/jco.2016.71.8726

  • Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors

    Cancer Cell · 2016 · 10.1016/j.ccell.2016.11.003

  • Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

    The Lancet Oncology · 2016 · 10.1016/s1470-2045(15)00581-1

  • Therapeutic Impact of Cytoreductive Surgery and Irradiation of Posterior Fossa Ependymoma in the Molecular Era: A Retrospective Multicohort Analysis

    Journal of Clinical Oncology · 2016 · 10.1200/jco.2015.65.7825

  • Poorly differentiated chordoma with SMARCB1/INI1 loss: a distinct molecular entity with dismal prognosis

    Acta Neuropathologica · 2016 · 10.1007/s00401-016-1574-9

  • Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysis

    The Lancet Oncology · 2015 · 10.1016/s1470-2045(15)70114-2

  • Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma

    Nature Genetics · 2014 · 10.1038/ng.2950

  • Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma

    Nature · 2014 · https://doi.org/10.1038/nature13379

  • Cytogenetic Prognostication Within Medulloblastoma Subgroups

    Journal of Clinical Oncology · 2014 · 10.1200/jco.2013.50.9539

  • Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas

    Acta Neuropathologica · 2013 · 10.1007/s00401-013-1095-8

  • Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR

    Nature Genetics · 2013 · 10.1038/ng.2849

  • DNA methylation profiling of medulloblastoma allows robust subclassification and improved outcome prediction using formalin-fixed biopsies

    Acta Neuropathologica · 2013 · 10.1007/s00401-012-1077-2

  • Subgroup-Specific Prognostic Implications of TP53 Mutation in Medulloblastoma

    Journal of Clinical Oncology · 2013 · 10.1200/jco.2012.48.5052

  • TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

    Acta Neuropathologica · 2013 · 10.1007/s00401-013-1198-2

  • Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma

    Cancer Cell · 2012 · https://doi.org/10.1016/j.ccr.2012.08.024

  • Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

    Nature · 2012 · https://doi.org/10.1038/nature10833

  • Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours

    British Journal of Cancer · 2009 · 10.1038/sj.bjc.6605179

  • Molecular Profiling Identifies Prognostic Subgroups of Pediatric Glioblastoma and Shows Increased YB-1 Expression in Tumors

    Journal of Clinical Oncology · 2007 · 10.1200/jco.2006.07.8626

  • Treatment Outcomes in Depression: Comparison of Remote Treatment Through Telepsychiatry to In-Person Treatment

    American Journal of Psychiatry · 2004 · 10.1176/appi.ajp.161.8.1471

Current projects

    No projects listed.